Here's Why I Haven't Bought SpaceX Stock and Probably Never Will

The article argues against buying SpaceX, citing a price-to-sales ratio of 58 versus 3.5 for the S&P 500, cash burn of about $10 billion in its last quarter, and only one quarter of profitability. The author also cites no dividend, limited confidence in assessing the business, and concerns about CEO Elon Musk’s focus. Despite these risks, shares were reported up 25% over the prior three months as of Oct. 22.

Analysis

The bearish case is strongest as a capital-allocation and valuation-risk argument, not as proof that the business is deteriorating. Accounting profit can coexist with heavy cash use when investment, working capital, or other cash-flow items are large; the key question is whether spending creates durable capacity and recurring revenue or requires repeated external funding. A sales multiple alone cannot answer that: segment economics, free-cash-flow conversion, liquidity, and dilution risk are missing.

Near term, the cautious framing may weigh on a momentum-sensitive stock, but a short is asymmetric if investors are pricing long-duration growth and the operating data are opaque. Over 1–3 months, reconcile reported earnings with operating cash flow, capex, cash balance, and financing; also test whether launch and satellite-network growth translates into improving unit economics. Over 6–18 months, sustained funding needs could constrain investment or dilute holders, while successful scale could make today’s cash consumption look transitional. Amazon’s Kuiper and Blue Origin are relevant competitive reference points, but the article supplies no evidence that SpaceX is losing share to them.

Contrarian point: a high price-to-sales comparison with the broad market may overstate valuation excess if growth, business mix, and eventual margins differ materially. Conversely, management complexity and multiple capital-intensive programs raise execution and capital-allocation risk. The thesis weakens if audited cash-flow disclosures show falling investment needs, improving free-cash-flow conversion, and growth without material dilution; it strengthens if liquidity declines or guidance signals persistent funding demands.

Key Decisions for Investors

• Avoid adding to SPCX solely on the growth narrative until segment revenue, cash-flow reconciliation, liquidity, and share-count trends are independently verified. The article’s figures are not enough to establish the funding runway or normalized economics.
• No outright short recommendation yet: the valuation concern is real, but absent verified financials and a defined catalyst, a crowded or momentum-driven rebound could dominate the timing. Reassess after the next filing or guidance update.
• Set an alert for deteriorating cash conversion, rising net financing needs, dilution, or weaker growth in recurring satellite services; these would make the downside thesis more actionable over the next 1–3 months.
• For a long thesis, require evidence over the next 6–18 months that investment converts into durable revenue and improving free cash flow. Failure to improve those measures—or a financing event that expands the share count—would falsify the scale-up case.